Join our community!

We believe in entrepreneurship in Haifa, and invite you to share a part of our journey


Get listed

Service provider?

Join us today

Have an Event?

Submit an event

Stay updated with our news! our newsletter now


Join our newsletter to be updated
on everything that happens in
entrepreneurship field in Haifa

Promise not to send spam!
You can unsubscribe any time

Home / Startups / Pluristem Therapeutics
Pluristem Therapeutics

Pluristem Therapeutics

Placental Cell Therapy to Stimulate Innate Healing Processes

Pluristem Therapeutics Inc is a clinical-stage biotechnology company using placental cells and a proprietary three-dimensional (3D) technology platform to develop cell therapies for a broad spectrum of diseases. Pluristem converts human placental cells into PLacental eXpanded (PLX) cells, which secrete therapeutic proteins in response to signals produced by damaged tissues. The companys pipeline targets multiple indications involving inflammation and ischemia, including peripheral artery disease, muscle injury, preeclampsia, and graft versus host disease. PLX cells require no tissue matching prior to administration, making them an off-the-shelf product. The companys GMP-certified in-house manufacturing facilities allow it to produce commercial quantities of homogeneous, clinical-grade PLX cells. Pluristem is one of the first companies to manufacture large quantities of placenta-based cell products using a 3D bioreactor.

Sectors: Pharmaceuticals

Year of establishment:


Fundraising stage:


Product/Service stage:

Clinical trial

Number of employees:


Contact Pluristem Therapeutics


MATAM, Building 5, Haifa 31905

Phone Number

Want some more?